Cantor Fitzgerald Reiterates Overweight on Biohaven
Biohaven Is Maintained at Overweight by JP Morgan
Biohaven Analyst Ratings
Bullish Biohaven Insiders Loaded Up On US$41.7m Of Stock
Biohaven CEO Vlad Coric Acquires $999,970 in Company Stock
J.P. Morgan Maintains Biohaven(BHVN.US) With Buy Rating, Announces Target Price $68
Strong Buy Rating for Biohaven Ltd. on Troriluzole's Market Potential and Robust Pipeline
Express News | Biohaven Ltd : JP Morgan Raises Target Price to $68 From $55
Express News | Biohaven Ltd: - Enters Underwriting Agreement With J.P. Morgan and Morgan Stanley
Biohaven Offering of 6.05M Shrs Closed at $47.50/Shr >BHVN
Sector Update: Health Care Stocks Steady Premarket Tuesday
TD Cowen Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $55
TD Cowen Sticks to Its Buy Rating for Biohaven Ltd. (BHVN)
Acuity Brands, Nike And 3 Stocks To Watch Heading Into Tuesday
After-hours Movers: IGM Biosciences, Biohaven Pharma, Acadia Realty Trust
Biohaven Announces Proposed $250M Public Offering Of Common Shares
Express News | Biohaven Announces Proposed Public Offering of Common Shares
Express News | Biohaven Ltd - Trial to Enroll 575 Patients Across 60 U.S. Sites
Express News | Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine
Hewlett Packard Enterprise, Nvidia, Progress Software And Other Big Stocks Moving Higher On Wednesday